Share of pregnant women with HIV that receive antiretroviral therapy in Libya
Libya: Share of pregnant women with HIV that receive antiretroviral therapy was 70.0% in 2023. ◆ Volatile
Share of pregnant women with HIV that receive antiretroviral therapy in Libya, 2000–2023
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of pregnant women living with HIV.
Analysis
Libya recorded 70.0% for share of pregnant women with hiv that receive antiretroviral therapy in 2023.
That represents a change of down 2.8% on the previous year and up 16.7% over ten years.
Over the whole period, share of pregnant women with hiv that receive antiretroviral therapy in Libya peaked at 72.0% in 2018 and was at its lowest, 0.0%, in 2000.
That places Libya 51st out of 84 countries with data for 2023, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 65.8% | 60.0% | 72.0% | 4 |
| 2020s | 71.0% | 70.0% | 72.0% | 4 |
Countries ranked near Libya
- 48 Algeria 74.0% compare
- 49 Gabon 72.0% compare
- 49 Morocco 72.0% compare
- 52 Burkina Faso 69.0% compare
- 52 Central African Republic 69.0% compare
- 54 Dominican Republic 68.0% compare
- 54 Laos 68.0% compare
More gender data for Libya
- Age population, age 00, female, interpolated 58,243 (2025)
- Age population, age 00, male, interpolated 61,596 (2025)
- Age population, age 01, female, interpolated 59,014 (2025)
- Age population, age 01, male, interpolated 62,364 (2025)
- Age population, age 02, female, interpolated 60,166 (2025)
- Age population, age 02, male, interpolated 63,519 (2025)
- Age population, age 03, female, interpolated 61,477 (2025)
- Age population, age 03, male, interpolated 64,892 (2025)
- Age population, age 04, female, interpolated 62,709 (2025)
- Age population, age 04, male, interpolated 66,186 (2025)
Frequently asked questions
- What is share of pregnant women with hiv that receive antiretroviral therapy in Libya?
- Share of pregnant women with hiv that receive antiretroviral therapy in Libya was 70.0% in 2023, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of pregnant women with hiv that receive antiretroviral therapy recorded in Libya?
- The highest recorded value was 72.0% in 2018.
- What is the lowest share of pregnant women with hiv that receive antiretroviral therapy recorded in Libya?
- The lowest recorded value was 0.0% in 2000.
- How does Libya rank for share of pregnant women with hiv that receive antiretroviral therapy?
- Libya ranks 51st out of 84 countries with data for 2023.
- Is share of pregnant women with hiv that receive antiretroviral therapy rising or falling in Libya?
- Over the last ten years it is up 16.7%. The long-run trend across the full record is volatile.
- Where does this Libya data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.